Scientists at the Institute of Cancer Research in London are contributing to an international clinical trial evaluating THEO-260, an experimental oncolytic immunotherapy designed to treat ...

Holcim has agreed to acquire Cemex’s building materials and solutions operations in Colombia in a transaction valued at USD 485 million. The acquisition includes more than 20 production sites such as ...